Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

2.320
-0.040-1.69%
Volume:14.77M
Turnover:33.92M
Market Cap:9.27B
PE:18.49
High:2.350
Open:2.350
Low:2.260
Close:2.360
52wk High:4.490
52wk Low:1.670
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:1.12
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.125
ROE:3.68%
ROA:2.41%
PB:0.55
PE(LYR):18.49
PS:1.32

Loading ...

LUYE PHARMA (02186) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express
·
Mar 17

LUYE PHARMA (02186) Monthly Return Announcement for February 2026

Bulletin Express
·
Mar 05

Luye Pharma Group Ltd. (02186) Announces January 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Feb 05

China Cinda Subsidiaries to Inject 285 Million Yuan into Luye Pharma Unit

MT Newswires Live
·
Jan 27

LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong

Stock News
·
Jan 27

LUYE PHARMA (02186): Nanjing LUYE Pharma Secures RMB 285 Million Capital Injection

Stock News
·
Jan 27

Luye Pharma (02186) Announces RMB285 Million Capital Injection in Nanjing Luye, Triggering Discloseable and Connected Transaction

Bulletin Express
·
Jan 27

Luye Pharma - Nanjing Xinan, Ningbo Cinda to Provide Further Capital to Nanjing Luye for Total RMB285 Mln on Jan 26

THOMSON REUTERS
·
Jan 27

Luye Pharma Completes Transfer of 25% Stake in Nanjing Luye to NJ Xinshi

Reuters
·
Jan 27

Shandong Boan Biotechnology Transfers 11.99 Million H Shares to Complete Minority Stake Deal

Reuters
·
Jan 26

BOAN BIOTECH (06955): Shandong Luye Pharmaceutical Plans Further Transfer of 38.5 Million H Shares to Luye Geneora Holding

Stock News
·
Jan 21

Shandong Boan Biotechnology Transfers 38.5 Million H Shares to New Investor

Reuters
·
Jan 21

A Look At Luye Pharma Group (SEHK:2186) Valuation After Ruoxinlin NDA Acceptance For Anxiety Disorder

Simply Wall St.
·
Jan 15

Shandong Boan Biotechnology Signs Finance Lease Agreement with Industrial Bank Financial Leasing

Reuters
·
Jan 14

LUYE PHARMA (02186): NDA for New Indication of Class 1 Innovative Drug Ruoxinlin® for Generalized Anxiety Disorder Accepted in China

Stock News
·
Jan 08

Luye Pharma - New Drug Application for Class 1 Innovative Drug Ruoxinlin for New Indication of Generalized Anxiety Disorder Accepted in China

THOMSON REUTERS
·
Jan 08

China Accepts Luye Pharma's NDA for Ruoxinlin in Generalized Anxiety Disorder

Reuters
·
Jan 08

Luye Pharma (02186): Xia Lian Appointed as Member of Nomination Committee

Stock News
·
Dec 31, 2025

Luye Pharma Appoints Xia Lian to Nomination Committee

Reuters
·
Dec 31, 2025

LUYE PHARMA (02186) Grants Exclusive Commercialization Rights for Three Long-Acting Antipsychotic Injections to Enhua in Mainland China

Stock News
·
Dec 24, 2025